Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2Recurrence 2Neoplasms 2Lymphoma 2Small Cell Lung Carcinoma 1Melanoma 1Lymphoma, Mantle-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Hematologic Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1COVID-19 1Advanced Solid Tumors 1Advanced Solid Malignancies 1

Interventions

Gemcitabine 28pembrolizumab 24Cisplatin 24Fluorouracil 11Leucovorin 10Oxaliplatin 8Nivolumab 7Capecitabine 6Irinotecan 5Drug Therapy 5pemigatinib 4futibatinib 4Paclitaxel 4Carboplatin 4ivosidenib 3fludarabine 3durvalumab 3derazantinib 3Folfox protocol 3Cyclophosphamide 3Bevacizumab 3zanidatamab 2spartalizumab 2olutasidenib 2lenvatinib 2infigratinib 2budigalimab 2Trastuzumab 2Ipilimumab 2Injections 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Cholangiocarcinoma × Rabeprazole × Clear all
NCT05930119 2023-09-06

HMPL-453 Food Effect and PPI Study in Healthy Volunteer Study

Hutchmed

Phase 1 Completed
24 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡